The Cooper Companies, Inc.

Equities

COO

US2166485019

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 04:00:00 2024-03-28 pm EDT 5-day change 1st Jan Change
101.5 USD -0.37% Intraday chart for The Cooper Companies, Inc. +0.09% +7.24%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Cooper Companies Insider Sold Shares Worth $5,521,230, According to a Recent SEC Filing MT
North American Morning Briefing : Markets on Hold -2- DJ
All eyes on the Fed Our Logo
ANALYST RECOMMENDATIONS : 3M Company, Snowflake, Splunk, Micron, Nvidia... Our Logo
Redburn Atlantic Upgrades Cooper Companies to Buy From Neutral, Adjusts Price Target to $125 From $93.75 MT
Not a care in the world Our Logo
JPMorgan Upgrades Cooper Companies to Overweight From Neutral, Adjusts Price Target to $120 From $100 MT
ANALYST RECOMMENDATIONS : Broadcom, Tesla, Walmart, Entain, Virgin Money UK Our Logo
Cooper Companies Insider Sold Shares Worth $24,659,342, According to a Recent SEC Filing MT
Piper Sandler Adjusts Price Target on Cooper to $115 From $110, Maintains Overweight Rating MT
Cooper to Benefit From Strong Contacts Market as Demand Continues, Morgan Stanley Says MT
Mizuho Adjusts Price Target on Cooper to $115 From $102.50, Maintains Buy Rating MT
Morgan Stanley Lifts Price Target on Cooper Cos. to $95 From $88.75 After Better-Than-Expected Fiscal Q1; Equalweight Kept MT
Cooper Companies lifts annual revenue forecast on strong contact lens demand RE
Transcript : The Cooper Companies, Inc., Q1 2024 Earnings Call, Feb 29, 2024
Cooper Fiscal Q1 Non-GAAP EPS, Net Sales Increase; Issues Outlook MT
The Cooper Companies, Inc. Raises its Revenue Guidance for the Fiscal Year 2024 CI
The Cooper Companies, Inc. Reports Earnings Results for the First Quarter Ended January 31, 2024 CI
Cooper Companies Guides For FY 2024 EPS of $3.50-$3.58 on Revenue of $3.847-$3.897 Billion, vs CIQ Analyst Consensus of $3.46/Share on Revenue of $3.86 Billion MT
Earnings Flash (COO) COOPERCOMPANIES Posts Q1 Revenue $931.6M, vs. Street Est of $917.5M MT
Earnings Flash (COO) COOPERCOMPANIES Reports Q1 EPS $0.85, vs. Street Est of $0.78 MT
Just as expected Our Logo
ANALYST RECOMMENDATIONS : Amex, Snowflake, Salesforce, Walmart, Nutrien... Our Logo
The calm after the storm Our Logo
ANALYST RECOMMENDATIONS : Amex, Apollo Global Management, Crowdstrike, Workday, Abrdn... Our Logo
Chart The Cooper Companies, Inc.
More charts
The Cooper Companies, Inc. is a global medical device company. The Company operates through two business units: CooperVision and CooperSurgical. CooperVision is engaged in the contact lens industry. CooperVision’s products include MyDay daily disposable, MyDay daily disposable toric, MyDay Energys, MyDay multifocal, Biofinity & Biofinity XR, Biofinity Energys, Biofinity toric & Biofinity XR toric, Biofinity multifocal, Biofinity toric multifocal, clariti 1 day, clariti 1 day toric, clariti 1 day multifocal, MiSight 1 day, Avaira Vitality and Avaira Vitality toric. CooperSurgical is a fertility and women’s health company dedicated to assisting women, babies and families around the world. CooperSurgical provides a range of products and services with an emphasis on improving fertility solutions, empowering office-based care, and advancing hospital care within women’s health. CooperSurgical’s brands include Paragard, ER-Complete, Fetal Pillow, INSORB, PGT-Complete, RUMI II and others.
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
101.5 USD
Average target price
107.4 USD
Spread / Average Target
+5.86%
Consensus
  1. Stock
  2. Equities
  3. Stock The Cooper Companies, Inc. - Nasdaq
  4. News The Cooper Companies, Inc.
  5. Cooper : KeyBanc Adjusts Cooper Companies' Price Target to $367 from $349, Keeps Overweight Rating